component-social-facebook_share_api-v2-01
      36
      Sunday
      53 / 35
      Monday
      57 / 28
      Tuesday
      47 / 26

      Congressman Bishop announces grant awarded to ASU

      Through the Understanding Non-Covalent Interaction in Carbon Nanotube/Anticancer Drug Conjugate project, Dr. Yixuan Wang and ASU students will research anti-cancer drug resistance.

      Today, Congressman Sanford D. Bishop, Jr. announced the following U.S. Department of Health and Human Services grant awarded to Albany State University (ASU) through the National Institute of Health (NIH).

      Through the Understanding Non-Covalent Interaction in Carbon Nanotube/Anticancer Drug Conjugate project, Dr. Yixuan Wang and ASU students will research anti-cancer drug resistance.

      I am very grateful for this opportunity extended to Albany State University to continue the advancement of vital cancer research, said Congressman Bishop. I commend the U.S. Department of Health and Human Services for its commitment to medical research and support of academic institutions like ASU, a historically African-American university. Well-funded research facilities are vital to improving America TMs cancer research portfolio. It is important to note that the NIH recognizes the significance of the type of anti-cancer research that Dr. Wang is doing here at ASU. Being federally funded brings universities like Albany State University to the forefront of cutting edge research, said Chanta Haywood, Interim Vice President for Institutional Advancement Research. Medical research like this project will benefit the people of Southwest Georgia and America, as well as the International community. HHS granted $105,160 dollars for the project. It will fund advanced medical research and will also provide resources for ASU to teach and train students for future projects. The university hopes that grants like this will continue to promote innovative research at minority institutions such as Albany State University.
      FOLLOW US ON TWITTER